Jun
17
Tue
Cancer Education Seminar Series: Molecular Biology of MPNs: Impact on Diagnosis, Prognosis, and Treatment @ Stanford Cancer Center CC 2103-2104
Jun 17 @ 8:00 am – 9:00 am
Cancer Education Seminar Series: Molecular Biology of MPNs: Impact on Diagnosis, Prognosis, and Treatment @ Stanford Cancer Center CC 2103-2104

Presenter: Jason Gotlib, MD, Associate Professor of Medicine (Hematology)

Jun
24
Tue
Cancer Education Seminar Series: Case-based approach to anticoagulation management @ Stanford Cancer Center CC 2103-2104
Jun 24 @ 8:00 am – 9:00 am
Cancer Education Seminar Series: Case-based approach to anticoagulation management @ Stanford Cancer Center CC 2103-2104

Presenter: Caroline Berube, Clinical Associate Professor of Medicine (Hematology)

Sep
30
Tue
Cancer Educ Seminar: Simulation Modeling of Lung and Breast Cancer Outcomes @ Stanford Cancer Center CC 2103-2104
Sep 30 @ 8:00 am – 9:00 am
Cancer Educ Seminar: Simulation Modeling of Lung and Breast Cancer Outcomes @ Stanford Cancer Center CC 2103-2104

Presenter: Sylvia Plevritis, PhD, Professor of Radiology (General Radiology)

Jun
16
Tue
Cancer Education Seminar: New Educational Aspects in Acute Myeloid Leukemia @ Stanford Cancer Center CC 2103-2104
Jun 16 @ 8:00 am – 9:00 am
Cancer Education Seminar: New Educational Aspects in Acute Myeloid Leukemia @ Stanford Cancer Center CC 2103-2104

Presenter: Bruno Medeiros, MD, Associate Professor of Medicine (Hematology)

Jun
23
Tue
Cancer Education Seminar: Recent Molecular and Clinical Advances in Myelodysplastic Syndrome @ Stanford Cancer Center CC 2103-2104
Jun 23 @ 8:00 am – 9:00 am
Cancer Education Seminar: Recent Molecular and Clinical Advances in Myelodysplastic Syndrome @ Stanford Cancer Center CC 2103-2104

Presenter: Peter Greenberg, MD, Professor (Emeritus) of Medicine (Hematology)

Jun
30
Tue
Cancer Education Seminar: Updates on Myeloma @ Stanford Cancer Center CC 2103-2104
Jun 30 @ 8:00 am – 9:00 am
Cancer Education Seminar: Updates on Myeloma @ Stanford Cancer Center CC 2103-2104

Presenter: Michaela Liedtke, MD, Assistant Professor of Medicine (Hematology)

May
30
Wed
Medicine Grand Rounds: Theranostics: The tale of a rare tumor, a receptor, and the FDA @ LKSC, Berg Hall
May 30 @ 8:00 am – 9:00 am
Medicine Grand Rounds: Theranostics: The tale of a rare tumor, a receptor, and the FDA @ LKSC, Berg Hall | Palo Alto | California | United States

Presenter: Pamela Kunz, MD
Assistant Professor of Oncology
Stanford University

Pamela Kunz, MD, specializes in the treatment of gastrointestinal malignancies with an expertise in the care of patients with neuroendocrine tumors (NETs). She has developed broad investigative programs in the field of neuroendocrine tumors, encompassing clinical trials, population sciences, and translational correlates. She is the Principal Investigator on numerous clinical trials. She is the Director of the Stanford Neuroendocrine Tumor Program. She currently serves on the National Comprehensive Cancer Network (NCCN) Neuroendocrine Tumors Guidelines Panel, the Neuroendocrine Tumor Taskforce of the National Cancer institute, the NANETS Guidelines and Executive Committees, and leads the NET Working Group of the Eastern Cooperative Oncology Group (ECOG).

Jul
25
Wed
Medicine Grand Rounds: Engineering T Cells for Cancer Therapy @ LKSC Berg Hall
Jul 25 @ 8:00 am – 9:00 am
Medicine Grand Rounds: Engineering T Cells for Cancer Therapy @ LKSC Berg Hall | Palo Alto | California | United States

Presenter: Crystal Mackall, MD
Professor of Pediatric Hematology/Oncology and Medicine                                                          Stanford University

Crystal L Mackall MD is Endowed Professor of Pediatrics and Internal Medicine at Stanford University. She serves as Founding Director of the Stanford Center for Cancer Cell Therapy, Associate Director of Stanford Cancer Institute, Leader of the Cancer Immunology and Immunotherapy Program at Stanford and Director of the Parker Institute for Cancer Immunotherapy at Stanford. During her tenure as Head of the Immunology Section and Chief of the Pediatric Oncology Branch, NCI, she built an internationally recognized translational research program spanning basic studies of T cell homeostasis and tumor immunology, and clinical trials of immune based therapies for cancer. Her work is credited with identifying an essential role for the thymus in human T cell regeneration and discovering IL-7 as the master regulator of T cell homeostasis. She has led numerous cutting edge and first-in-human and first-in-child clinical trials spanning dendritic cell vaccines, cytokines, and adoptive immunotherapy using NK cells and genetically modified T cells. Her group was among the first to demonstrate impressive activity of CD19-CAR in pediatric leukemia and recently demonstrated impressive activity of a second CAR targeting CD22.. Dr. Mackall’s clinical trials are notable for the incorporation of deep biologic endpoints that further our understanding of the basis for success and failure of the agent under study. She has published over 175 manuscripts and serves in numerous leadership positions, including Leader of the NCI Pediatric Cancer Immunotherapy Trials Network, co-Leader of the St. Baldrick’s-StandUp2Cancer Pediatric Dream Team. She is Board Certified in Pediatrics and Internal Medicine.
Sep
16
Mon
12th Comprehensive Cancer Research Training Program (CCRTP) @ Bechtel Conference Center, Encina Hall
Sep 16 – Sep 17 all-day
12th Comprehensive Cancer Research Training Program (CCRTP) @ Bechtel Conference Center, Encina Hall

The Comprehensive Cancer Research Training Program is an annual two–day immersive course that invites graduate and postdoctoral students, residents, clinical fellows and research fellows to take part in a unique, comprehensive introduction to the vanguard of current cancer research.

This ambitious curriculum features daily plenary sessions on general topics followed by half-day sessions on two scientific themes, each featuring three to four presentations. Numerous nationally and internationally renowned Stanford faculty present didactic lectures and discussions on current topics of basic, translational and clinical cancer research.

REGISTER HERE.

Sep
24
Tue
The 2019 Early Detection of Cancer Conference @ Frances C. Arrillaga Alumni Center
Sep 24 – Sep 26 all-day
The 2019 Early Detection of Cancer Conference @ Frances C. Arrillaga Alumni Center

The Canary Center at Stanford, founded in 2009 as the first research center in the world, entirely dedicated to cancer early detection, The Knight Cancer Institute at Oregon Health & Science University, a leader in precision cancer medicine, and Cancer Research UK, the largest independent funder of cancer research globally have formed an international collaboration to accelerate research in the early detection of cancer.

The goal of this unique trans-Atlantic agreement is to find lethal cancers as they’re forming so they can be treated more effectively. Survival increases significantly when the disease is treated at an early stage.

The collaboration also seeks to accelerate progress by breaking down barriers for scientists, including:

  • A lack of cohorts of sufficient size and a shortage of clinical samples available for research
  • Development and deployment of new technologies
  • Lack of understanding of the biology of early cancer and technologies to detect its features

2019 conference topic list includes:

  • Integrative Early Detection through multiple technologies
  • Prognostic Early Detection
  • Signals from beyond the tumor
  • Integrative Susceptibility for Early Detection
  • Fostering a translational mentality in Early Detection Research

CLICK HERE TO REGISTER.